{
    "2019-12-24": [
        [
            {
                "time": "2018-12-24",
                "original_text": "智通港股公告精选︱(12.24)南方航空将正式退出天合联盟 将启用“南航优享CZ Priority”",
                "features": {
                    "keywords": [
                        "南方航空",
                        "天合联盟",
                        "退出",
                        "南航优享"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "航空"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "格隆汇港股聚焦(12.24)︱谢永林正式出任中国平安总经理 贝莱德增持中广核电力9531万股",
                "features": {
                    "keywords": [
                        "谢永林",
                        "中国平安",
                        "贝莱德",
                        "增持",
                        "中广核电力"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险",
                        "电力"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "24日晚公告精选丨8天7板后星期六股东集体减持",
                "features": {
                    "keywords": [
                        "星期六",
                        "减持"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "其他"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "公告精选：圣农发展前三季度拟10派15元；星期六控股股东方面拟减持不超5%股份",
                "features": {
                    "keywords": [
                        "圣农发展",
                        "分红",
                        "星期六",
                        "减持"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品加工",
                        "其他"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "上海医药：子公司药品通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "上海医药(601607.SH)：马来酸依那普利片通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "马来酸依那普利片",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-24",
                "original_text": "上海医药(02607.HK)子公司马来酸依那普利片通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "上海医药",
                        "马来酸依那普利片",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}